# GSIN Governance Charter
## Global Surgical Intelligence Network — Formal Governance Charter
### Version 1.0 | Effective: P23

---

## Preamble

This Charter establishes the governance structure, operating procedures, and accountability standards for the Global Surgical Intelligence Network (GSIN). The GSIN is committed to advancing surgical instrument quality and patient safety through the responsible, privacy-preserving sharing of anonymized aggregate intelligence across participating healthcare organizations worldwide.

All GSIN activities are governed by the principles of privacy by design, data minimization, human oversight, and accountability. No GSIN output establishes causation, constitutes a regulatory decision, or replaces human clinical and quality judgment.

---

## Article 1 — GSIN Governance Board

### 1.1 Composition

The GSIN Governance Board (Board) consists of eight members:

| Seat | Count | Selection Method | Term |
|------|-------|-----------------|------|
| Hospital Representative | 3 | Elected by hospital participant tenants | 2 years |
| Vendor Organization Representative | 2 | Elected by vendor participant tenants | 2 years |
| Independent Clinical Advisor | 1 | Appointed by Board vote | 2 years |
| Privacy Officer | 1 | Appointed by Board vote | 2 years |
| Technical Security Representative | 1 | Appointed by Board vote | 2 years |

No single organization may hold more than one Board seat at a time.

### 1.2 Voting Rules

- **Quorum:** 5 of 8 Board members required for any vote.
- **Simple majority (5+ of quorum):** Routine decisions, agenda items, operational matters.
- **Two-thirds supermajority (6+ of 8 members):** Signal publication policy changes, participant suspension or termination, Charter amendments, new data category approval.
- **Unanimous (8 of 8):** Dissolution of the GSIN.

### 1.3 Meeting Schedule

- **Regular meetings:** Quarterly (minimum).
- **Emergency meetings:** Convened within 72 hours when an escalated recall warning signal requires Board review or when a data breach or privacy incident is reported.
- **Annual Review Meeting:** Conducted each calendar year to review governance maturity, update policies, and confirm Board membership.

### 1.4 Conflict of Interest

Board members must disclose conflicts of interest before any vote affecting organizations they represent. Members with disclosed conflicts are recused from the relevant vote. Conflict disclosures are recorded in Board meeting minutes.

### 1.5 Removal

A Board member may be removed by a two-thirds supermajority vote of the remaining Board members for:
- Violation of this Charter
- Breach of participant confidentiality
- Failure to attend three consecutive regular meetings without documented cause

---

## Article 2 — Signal Publication Standards

### 2.1 Publication Criteria

A GSIN signal is eligible for publication to the network only when ALL of the following criteria are satisfied:

1. **k-Anonymity Verified:** The signal includes data from at least 10 (k≥10) distinct participating facilities. For recall early warning signals, the threshold is N≥5 facilities for initial detection, but published signals require k≥10.

2. **Differential Privacy Applied:** Laplace mechanism noise with ε≤0.05 has been applied to all rate and count data in the signal.

3. **Human Review Completed:** At least one Board member or designated reviewer has reviewed the signal content and confirmed it meets publication standards.

4. **Disclaimer Attached:** The signal includes the standard disclaimer text confirming it does not establish causation, does not identify individual facilities or patients, and requires human review before any action.

5. **Association Reason Documented:** The signal includes an association_reason field explaining the observed pattern in association-not-causation language.

6. **Causation Language Absent:** The signal content has been reviewed and confirmed to contain no language claiming or implying causation.

### 2.2 Prohibited Signal Content

Published signals must not contain:
- Facility names, facility IDs, or facility pseudonyms
- Patient identifiers of any kind (name, MRN, DOB, SSN, or equivalent)
- Specific instrument serial numbers or asset IDs
- Specific manufacturer names (generalized to tier/category only)
- Geographic precision below regional level (e.g., no city-level data)

### 2.3 Signal Review Turnaround

- **Standard signals:** Human review completed within 5 business days of threshold being met.
- **Escalated recall warnings:** Emergency Board review within 72 hours.
- **Regulatory evidence packages:** Review completed within 10 business days.

### 2.4 Signal Lifecycle

```
[Monitoring] → [Threshold Met] → [Human Review] → [Published]
                                        │
                               [Returned — revision required]
                                        │
                               [Resolved — archived]
```

---

## Article 3 — Privacy Review Process

### 3.1 Quarterly Privacy Review

The Privacy Officer conducts a quarterly privacy review covering:
- All signal types published in the quarter
- Any new data category introduced in the quarter
- k-anonymity verification audit (sample of 10% of published signals)
- Differential privacy budget tracking
- Participant complaint and dispute log
- Cross-border transfer compliance status

### 3.2 New Data Category Approval

Before any new signal type or data category is introduced to the GSIN pipeline:
1. Technical Security Representative conducts a data flow privacy impact assessment.
2. Privacy Officer reviews and approves or rejects.
3. Board vote (two-thirds supermajority) required for approval.
4. Participant notification issued at least 30 days before new category goes live.

### 3.3 Privacy Incident Response

If a privacy incident is identified (potential re-identification, data breach, unauthorized access):
1. Incident reported to Privacy Officer and Technical Security Representative immediately.
2. Emergency Board meeting convened within 72 hours.
3. Affected participants notified within the timeframe required by applicable law (HIPAA: 60 days; GDPR: 72 hours to supervisory authority; PIPEDA: as soon as feasible).
4. Incident root cause analysis completed within 30 days.
5. Remediation plan reviewed and approved by Board.

### 3.4 Annual Privacy Audit

An independent third-party privacy audit is conducted annually covering:
- k-anonymity implementation
- Differential privacy parameter compliance
- Facility pseudonymization salt rotation
- Cross-border transfer control documentation
- Access control review

Audit findings are reviewed by the Board at the Annual Review Meeting.

---

## Article 4 — Participant Onboarding Requirements

### 4.1 Legal Requirements

All participants must complete the following legal agreements before activation:

| Jurisdiction | Required Agreement |
|-------------|-------------------|
| United States | Business Associate Agreement (BAA) per HIPAA |
| European Union | Data Processing Agreement (DPA) per GDPR Article 28 |
| United Kingdom | Data Processing Agreement (UK GDPR / IDTA) |
| Australia | Data sharing agreement (Privacy Act 1988) |
| Canada | Data Processing Agreement (PIPEDA/Law 25) |
| Japan | Cross-border transfer agreement (APPI) |
| South Korea | Data Processing Agreement (PIPA) |

### 4.2 Security Requirements

- Annual security attestation: SOC 2 Type II report, ISO 27001 certification, or equivalent assessed by the Technical Security Representative.
- Network integration test: Validated GSIN API integration in staging environment before production activation.
- Security contact: Designated security contact registered with GSIN for incident response.

### 4.3 Governance Training

All participant administrators must complete GSIN data governance training before activation, covering:
- GSIN data sharing principles
- Contribution category configuration
- Privacy controls and prohibitions
- Dispute mechanism procedures

Training must be renewed annually.

### 4.4 Contribution Commitment

Participants confirm their intended contribution categories and commit to the minimum contribution threshold of 100 inspections per month over a 90-day rolling window to qualify for benchmark intelligence access.

### 4.5 Activation Process

```
[Application] → [Legal Review] → [Security Assessment] → [Integration Test]
     → [Governance Training] → [Board Approval] → [Active Status]
```

Board approval is required for all new participants. Approval is granted by simple majority vote.

---

## Article 5 — Dispute Resolution Process

### 5.1 Grounds for Dispute

A participant may dispute a published GSIN signal on the following grounds:
- Signal content incorrectly characterizes patterns associated with the participant's product category
- Signal was published in violation of k-anonymity or publication standards
- Signal contains prohibited content (identifiable information, causation language)
- Signal was published without required human review

### 5.2 Dispute Submission

Disputes must be submitted in writing to the GSIN Governance Board within 60 days of signal publication. Submissions must include:
- Signal identifier
- Grounds for dispute (citing specific standards violated)
- Supporting evidence or analysis
- Requested remedy (withdrawal, correction, or annotation)

### 5.3 Review Process

1. Board acknowledges receipt within 5 business days.
2. Signal placed under_review status during dispute period.
3. Board conducts review within 30 days.
4. Privacy Officer and Technical Security Representative provide technical assessment.
5. Board issues written determination by majority vote.
6. Disputed party notified of determination within 5 business days.

### 5.4 Remedies

The Board may order:
- **Withdrawal:** Signal unpublished and moved to resolved status.
- **Correction:** Signal content corrected and re-reviewed before republication.
- **Annotation:** Dispute annotation attached to signal (visible to network participants).
- **No action:** Dispute found not to meet grounds for remedy.

### 5.5 Appeal

A participant may appeal a Board determination within 30 days by requesting an independent review. The Board appoints an independent reviewer (not a current Board member). The independent reviewer's determination is final.

---

## Article 6 — Annual Review Cycle

### 6.1 Annual Review Scope

Each calendar year, the Annual Review Meeting addresses:

1. **Governance Maturity:** Progress against governance maturity model (Levels 1–5).
2. **Signal Quality Review:** Sample audit of published signals for standards compliance.
3. **Privacy Audit Results:** Review of third-party privacy audit findings and remediation status.
4. **Participant Satisfaction:** Survey results from participating organizations.
5. **Board Composition:** Confirmation of Board members; elections and appointments as needed.
6. **Charter Amendments:** Review and vote on any proposed Charter changes.
7. **Deployment Roadmap:** Review of phase progress and upcoming expansion milestones.
8. **Regulatory Engagement:** Update on regulatory authority engagement and evidence exchange status.

### 6.2 Annual Report

The Board publishes an Annual Report covering:
- Participant count and distribution by type and region
- Signal publication statistics (total published, by category, by region)
- Privacy audit summary
- Governance Board composition
- Dispute resolution summary (anonymized)
- Upcoming year priorities

The Annual Report is shared with all active participants and made available to regulatory observer participants.

### 6.3 Charter Amendment Process

Proposed Charter amendments must be:
1. Submitted in writing to the Board at least 30 days before the Annual Review Meeting.
2. Distributed to all participants for comment at least 14 days before the vote.
3. Approved by two-thirds supermajority Board vote.
4. Effective 30 days after adoption, with participant notification.

---

## Article 7 — Participant Obligations and Enforcement

### 7.1 Participant Obligations

All active participants agree to:
- Contribute only aggregated, anonymized data (no raw records, no patient data)
- Maintain current legal agreements and security attestation
- Report suspected privacy incidents to the GSIN within 24 hours
- Complete annual governance training renewal
- Abide by this Charter and GSIN signal contribution standards

### 7.2 Enforcement

Violations of participant obligations may result in:

| Violation | Response |
|-----------|----------|
| Minor technical violation | Written notice; 30-day remediation period |
| Repeated technical violations | Suspended status pending remediation |
| Privacy data submission (prohibited content) | Immediate suspension; Board review within 72 hours |
| Charter violation | Suspension or termination by Board two-thirds vote |
| Deliberate misrepresentation | Termination by Board two-thirds vote |

### 7.3 Suspended Status

During suspension, participants:
- Cannot contribute new signals
- Retain read-only access to previously published intelligence
- Must remediate identified issues within 60 days or face termination review

### 7.4 Reinstatement

Suspended participants may request reinstatement after demonstrating remediation to the Board's satisfaction. Reinstatement requires simple majority Board vote.

---

## Article 8 — Disclaimer and Limitation of Liability

All GSIN outputs, signals, registry entries, recall warnings, and regulatory evidence packages:

- Represent anonymized aggregate patterns across participating facilities only
- Do not identify any individual facility, patient, instrument, or product
- Do not establish, imply, or claim causation
- Do not constitute regulatory recalls, safety notices, or compliance determinations
- Do not replace human clinical and quality review
- Require human review and professional judgment before any operational decision

The GSIN and its Governance Board make no representations regarding the completeness, accuracy, or fitness for purpose of any published intelligence. Participants rely on GSIN outputs at their own professional judgment and risk.

---

*This Charter was adopted in accordance with the GSIN founding governance framework and is effective as of the P23 platform milestone.*
